New diabetes clinical trial: Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes

Published on: September 23, 2022 at 11:00AM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Tirzepatide;   Drug: Insulin Glargine
Sponsor:   Nanjing First Hospital, Nanjing Medical University
Recruiting
https://ift.tt/OVX95SM